SECOND AMENDED AND RESTATED JOINT VENTURE AGREEMENTJoint Venture Agreement • November 7th, 2018 • Novavax Inc • Biological products, (no disgnostic substances)
Cadila Pharmaceuticals Limited, a company incorporated under the laws of India having its office at ‘Cadila Corporate Campus’, Sarkhej-Dholka Road, Bhat, Ahmedabad - 382210, Gujarat, India herein represented by Dr. Rajiv I. Modi in his capacity as Chairman & Managing Director (hereinafter referred to as “Cadila”) which expression shall unless repugnant to the context or meaning thereof mean and include its scuccessors and permitted assigns and;
SECOND AMENDED AND RESTATED NOVAVAX PRODUCT LICENSE AGREEMENTProduct License Agreement • November 7th, 2018 • Novavax Inc • Biological products, (no disgnostic substances)
This SECOND AMENDED AND RESTATED NOVAVAX PRODUCT LICENSE AGREEMENT (the “Agreement”) is effective as of the 17th day of July, 2018 (the “Effective Date”), by and between
